CN101429124B - Synthesis of (7-methoxy-1-naphthyl) ethyl acetate - Google Patents

Synthesis of (7-methoxy-1-naphthyl) ethyl acetate Download PDF

Info

Publication number
CN101429124B
CN101429124B CN2007100480418A CN200710048041A CN101429124B CN 101429124 B CN101429124 B CN 101429124B CN 2007100480418 A CN2007100480418 A CN 2007100480418A CN 200710048041 A CN200710048041 A CN 200710048041A CN 101429124 B CN101429124 B CN 101429124B
Authority
CN
China
Prior art keywords
ethyl acetate
naphthyl
benzoquinones
methoxyl group
dihydro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2007100480418A
Other languages
Chinese (zh)
Other versions
CN101429124A (en
Inventor
唐家邓
李林
岑均达
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Institute of Pharmaceutical Industry
Original Assignee
Shanghai Institute of Pharmaceutical Industry
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Institute of Pharmaceutical Industry filed Critical Shanghai Institute of Pharmaceutical Industry
Priority to CN2007100480418A priority Critical patent/CN101429124B/en
Publication of CN101429124A publication Critical patent/CN101429124A/en
Application granted granted Critical
Publication of CN101429124B publication Critical patent/CN101429124B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The invention discloses a method for synthesizing (7-methoxyl-1-naphthyl) acetic ether (a formula II). The method comprises the following steps: in an inert organic solvent, substituted benzoquinone is used as an aromatized dehydrogenation reagent and (7-methoxyl-3,4-dihydro-1-naphthyl) acetic ether (a formula IV) as an aromatization substrate for aromatization reaction. The method has the advantages of mild condition, full aromatization reaction, high yield and high purity.

Description

The synthetic method of a kind of (7-methoxyl group-1-naphthyl) ethyl acetate
Technical field
The present invention relates to a kind of synthetic method of midbody compound, be specifically related to the synthetic method of a kind of (7-methoxyl group-1-naphthyl) ethyl acetate.
Background technology
Agomelatine, i.e. N-[2-(7-methoxyl group-1-naphthyl) ethyl] ethanamide (formula I), be a kind of melatonin receptor agonist, also be a kind of 5-HT 2CThe antagonist of acceptor has good pharmacologically active at treatment dysthymia disorders, the seasonal aspects such as fatigue, appetite disorder and obesity that constrain disorder, somnopathy, cardiovascular system diseases, digestive system, insomnia and cause owing to jet lag.
Figure S2007100480418D00011
(7-methoxyl group-1-naphthyl) ethyl acetate (formula II) is the key intermediate of synthetic Agomelatine.The synthetic method of ethyl acetate (formula II) that patent documentation EP 447285 has reported a kind of (7-methoxyl group-1-naphthyl): (7-methoxyl group-3,4-dihydro-1 (2H)-naphthylene base) ethyl acetate (formula III) is in the presence of sulphur, get final product through high temperature (215 ℃) reaction, reaction formula is as follows.But aromatization is incomplete in this method, and severe reaction conditions.
Figure S2007100480418D00021
Summary of the invention
Technical problem to be solved by this invention is to react not exclusively for the method that overcomes synthetic (7-methoxyl group-1-naphthyl) ethyl acetate (formula II) of prior art, and the defective of severe reaction conditions, and a kind of reaction conditions gentleness is provided, react completely, and yield and the high synthetic method of purity.
Method of the present invention comprises the steps: in the inert organic solvents, to replace benzoquinones is aromizing dehydrogenation reagent, with suc as formula (the 7-methoxyl group-3 shown in the IV, 4-dihydro-1-naphthyl) ethyl acetate is the aromizing substrate, carries out aromatization and can make suc as formula (7-methoxyl group-1-naphthyl) ethyl acetate shown in the II.
Figure S2007100480418D00022
Wherein, described replacement benzoquinones can be the carbonyl position of replacement at contraposition or adjacent benzoquinones, as 1 of replacement, 4-benzoquinones and 1,2-benzoquinones, substituting group are generally chlorine or cyano group, preferable is 2,3,5,6-tetrachloro-1,4-benzoquinones, 2,3-two chloro-5,6-dicyano-1,4-benzoquinones (DDQ) and 3,4,5,6-tetrachloro-1, one or more in the 2-benzoquinones.The mole dosage of described aromizing dehydrogenation reagent and (7-methoxyl group-3,4-dihydro-1-naphthyl) ethyl acetate than preferable be 1: 1~5: 1, better is 1: 1~2: 1.What the adding mode of described (7-methoxyl group-3,4-dihydro-1-naphthyl) ethyl acetate was preferable is the dropping mode, and what the speed of dropping was preferable is 1~5 of per second, and what temperature was preferable during dropping is controlled at 10~20 ℃.Described inert organic solvents is preferable is selected from methylene dichloride, chloroform, tetracol phenixin, ethyl acetate, tetrahydrofuran (THF) and the toluene one or more.The consumption of described organic inert solvent can be 2~20 times of reactant solubilized amount.What the temperature of described reaction was preferable is 0~60 ℃, and better is 10~20 ℃.The described reaction times is detected control with TLC, till finishing with base consumption.The developping agent that TLC detects can be sherwood oil: ethyl acetate=10: 1, product Rf=0.5.
Among the present invention, described suc as formula (the 7-methoxyl group-3 shown in the IV, 4-dihydro-1-naphthyl) ethyl acetate can be that method in the application for a patent for invention " synthetic method of a kind of (7-methoxyl group-3,4-dihydro-1-naphthyl) ethyl acetate " on November 9th, 2007 is prepared with reference to the applying date.Concrete steps are:
In non-protonic solvent, under the existence of organic bases, 7-methoxyl group naphthane-1-ketone and diethoxy phosphonoacetic acid ethyl ester reacted get final product.Among the present invention, Et represents ethyl.
Figure S2007100480418D00031
Wherein, what the mol ratio of described 7-methoxyl group naphthane-1-ketone and diethoxy phosphonoacetic acid ethyl ester was preferable is 1: 1~1: 5, and better is 1: 1.5~1: 2.5.Described organic bases is preferable is selected from sodium methylate, sodium ethylate, sodium isopropylate, potassium tert.-butoxide and the sodium hydride one or more, and better is sodium ethylate.The consumption of described organic bases is preferable is 1~5 times of substrate 7-methoxyl group naphthane-1-ketone molar weight, and better is 1.5~2.5 times.Described non-protonic solvent is preferable is selected from tetrahydrofuran (THF), ethyl acetate, 1, and 4-dioxane and N, one or more in the dinethylformamide, the consumption of solvent are 2~20 times of reactant solubilized amount.What the temperature of described reaction was preferable is 0~150 ℃, and better is 60~80 ℃.The time of reaction is detected control by TLC, and till naphthane-1-ketone ran out of with substrate 7-methoxyl group, developping agent was a sherwood oil: ethyl acetate=10: 1, product Rf=0.5.Reaction is after column chromatography, and the molar ratio of (7-methoxyl group-3,4-dihydro-1-naphthyl) ethyl acetate (formula IV) and (7-methoxyl group-3,4-dihydro-1 (2H)-naphthylene base) ethyl acetate (formula III) can reach 8: 1~11: 1, and yield is higher, and purity is higher.
Except that specifying, agents useful for same and raw material are all commercially available to be got among the present invention.
Positive progressive effect of the present invention is: method mild condition of the present invention, aromatization is complete, yield height, purity height.
Embodiment
Mode below by embodiment further specifies the present invention, but does not therefore limit the present invention among the described scope of embodiments.
Synthesizing of embodiment 1 (7-methoxy-1-naphthyl) ethyl acetate
2,3-two chloro-5,6-dicyano-1, (DDQ, 8.12g 36mmol) are dissolved in the dry methylene chloride (100ml) the 4-benzoquinones, keep temperature to drip (7-methoxyl group-3 down for 10-15 ℃, 4-dihydro-1-naphthyl) ethyl acetate (6.6g, methylene dichloride 26.8mmol) (50ml) solution, 2 of rate of addition per seconds.Dripping Bi Shengzhi room temperature (25 ℃) stirred 1 hour.With reacting liquid filtering, filtrate is washed (50ml * 3) with saturated sodium bicarbonate solution, washing, and the salt washing, anhydrous magnesium sulfate drying, the dried solvent of concentrating under reduced pressure gets 5.9g colorless oil product, yield 90.8%, purity 98.5%.Qualification result: 1H NMR (CDCl 3, 400M) δ: 1.18 (t, J=6.8Hz, 3H), 3.88 (s, 3H), 4.08-4.13 (m, 4H), 7.20 (dd, J=2.4Hz and 8.8Hz, 1H), 7.27-7.33 (m, 2H), 7.40 (d, J=6.8Hz, 1H), 7.78 (d, J=8.0Hz, 1H), 7.86 (d, J=9.2Hz, 1H)
Synthesizing of embodiment 2 (7-methoxy-1-naphthyl) ethyl acetate
2,3,5,6-tetrachloro-1, (8.86g 36mmol) is dissolved in the dry toluene (100ml) the 4-benzoquinones, keeps temperature to drip (7-methoxyl group-3 down for 10 ℃, 4-dihydro-1-naphthyl) ethyl acetate (6.6g, toluene 26.8mmol) (50ml) solution, 2 of rate of addition per seconds.Drip and finish 10 ℃ of stirrings of maintenance temperature 2 hours.With reacting liquid filtering, filtrate is washed (50ml * 3) with saturated sodium bicarbonate solution, washing, and the salt washing, anhydrous magnesium sulfate drying, the dried solvent of concentrating under reduced pressure gets 5.7g colorless oil product, yield 87.7%, purity 97.1%.Qualification result such as embodiment 1.
Synthesizing of embodiment 3 (7-methoxy-1-naphthyl) ethyl acetate
2,3-two chloro-5,6-dicyano-1, (6.06g 26.8mmol) is dissolved in the dry chloroform (100ml) the 4-benzoquinones, keeps temperature to drip (7-methoxyl group-3 down for 0 ℃, 4-dihydro-1-naphthyl) ethyl acetate (6.6g, chloroform 26.8mmol) (50ml) solution, 5 of rate of addition per seconds.Dripping to finish keeps 0 ℃ to stir 3 hours.With reacting liquid filtering, filtrate is washed (50ml * 3) with saturated sodium bicarbonate solution, washing, and the salt washing, anhydrous magnesium sulfate drying, the dried solvent of concentrating under reduced pressure gets 5.8g colorless oil product, yield 89.2%, purity 96.5%.Qualification result such as embodiment 1.
Synthesizing of embodiment 4 (7-methoxy-1-naphthyl) ethyl acetate
3,4,5,6-tetrachloro-1, (8.86g 36mmol) is dissolved in the dry ethyl acetate (100ml) the 2-benzoquinones, keeps temperature to drip (7-methoxyl group-3 down for 5-10 ℃, 4-dihydro-1-naphthyl) ethyl acetate (1.77g, ethyl acetate 7.2mmol) (50ml) solution, 3 of rate of addition per seconds.Dripping Bi Shengzhi stirred 1 hour for 20 ℃.With reacting liquid filtering, filtrate is washed (50ml * 3) with saturated sodium bicarbonate solution, washing, and the salt washing, anhydrous magnesium sulfate drying, the concentrating under reduced pressure solvent gets 6.0g colorless oil product, yield 92.3%, purity 97.9% to doing.Qualification result such as embodiment 1.
Synthesizing of embodiment 5 (7-methoxy-1-naphthyl) ethyl acetate
2,3,5,6-tetrachloro-1, (8.86g 36mmol) is dissolved in the dry tetrahydrofuran (100ml) the 4-benzoquinones, keeps temperature to drip (7-methoxyl group-3 down for 15-20 ℃, 4-dihydro-1-naphthyl) ethyl acetate (4.43g, tetrahydrofuran (THF) 18mmol) (50ml) solution, 1 of rate of addition per second.Dripping Bi Shengzhi stirred 1 hour for 60 ℃.With reacting liquid filtering, filtrate is washed (50ml * 3) with saturated sodium bicarbonate solution, washing, and the salt washing, anhydrous magnesium sulfate drying, the dried solvent of concentrating under reduced pressure gets 6.0g colorless oil product, yield 92.3%, purity 96.9% to doing.Qualification result such as embodiment 1.

Claims (10)

1. synthetic method suc as formula (7-methoxyl group-1-naphthyl) ethyl acetate shown in the II, it is characterized in that comprising the steps: in the inert organic solvents, to replace benzoquinones is aromizing dehydrogenation reagent, with suc as formula (the 7-methoxyl group-3 shown in the IV, 4-dihydro-1-naphthyl) ethyl acetate is the aromizing substrate, carries out aromatization and gets final product; Described benzoquinones is selected from 1 of replacement, 4-benzoquinones and 1, and 2-benzoquinones, substituting group are chlorine or cyano group.
2. the method for claim 1, it is characterized in that: described replacement benzoquinones is 2,3-two chloro-5,6-dicyano-1,4-benzoquinones, 2,3,5,6-tetrachloro-1,4-benzoquinones and 3,4,5,6-tetrachloro-1, one or more in the 2-benzoquinones.
3. the method for claim 1 is characterized in that: described aromizing dehydrogenation reagent is 1: 1~5: 1 with the mole dosage ratio of (7-methoxyl group-3,4-dihydro-1-naphthyl) ethyl acetate.
4. method as claimed in claim 3 is characterized in that: described aromizing dehydrogenation reagent is 1: 1~2: 1 with the mole dosage ratio of (7-methoxyl group-3,4-dihydro-1-naphthyl) ethyl acetate.
5. the method for claim 1 is characterized in that: the adding mode of described (7-methoxyl group-3,4-dihydro-1-naphthyl) ethyl acetate is for dripping.
6. method as claimed in claim 5 is characterized in that: the speed of described dropping is 1~5 of per second.
7. method as claimed in claim 5 is characterized in that: the temperature during described the dropping is controlled at 10~20 ℃.
8. the method for claim 1, it is characterized in that: the temperature of described reaction is 0-60 ℃.
9. method as claimed in claim 8 is characterized in that: the temperature of described reaction is 10-20 ℃.
10. the method for claim 1, it is characterized in that: described inert organic solvents is selected from one or more in methylene dichloride, chloroform, tetracol phenixin, ethyl acetate, tetrahydrofuran (THF) and the toluene.
CN2007100480418A 2007-11-09 2007-11-09 Synthesis of (7-methoxy-1-naphthyl) ethyl acetate Expired - Fee Related CN101429124B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2007100480418A CN101429124B (en) 2007-11-09 2007-11-09 Synthesis of (7-methoxy-1-naphthyl) ethyl acetate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2007100480418A CN101429124B (en) 2007-11-09 2007-11-09 Synthesis of (7-methoxy-1-naphthyl) ethyl acetate

Publications (2)

Publication Number Publication Date
CN101429124A CN101429124A (en) 2009-05-13
CN101429124B true CN101429124B (en) 2011-10-26

Family

ID=40644794

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2007100480418A Expired - Fee Related CN101429124B (en) 2007-11-09 2007-11-09 Synthesis of (7-methoxy-1-naphthyl) ethyl acetate

Country Status (1)

Country Link
CN (1) CN101429124B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104693026B (en) * 2014-09-24 2016-08-17 长沙理工大学 A kind of synthetic method of 1,2-glycol diesters

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5194614A (en) * 1990-02-27 1993-03-16 Adir Et Compagnie Compounds having a naphthalene structure

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5194614A (en) * 1990-02-27 1993-03-16 Adir Et Compagnie Compounds having a naphthalene structure

Also Published As

Publication number Publication date
CN101429124A (en) 2009-05-13

Similar Documents

Publication Publication Date Title
CN102633713B (en) Dabigatran etexilate intermediate, preparation method for same and method for preparing dabigatran etexilate
RU2682660C9 (en) Method of obtaining pde4 inhibitor
TWI398428B (en) New process for the synthesis of agomelatine
US9856215B2 (en) Preparation method of Nintedanib
CZ20023665A3 (en) Shortened synthesis of 3,3-diarylpropylamine derivatives
CN103619832A (en) Process for the manufacture of dabigatran etexilate and intermediates thereof
CN101429124B (en) Synthesis of (7-methoxy-1-naphthyl) ethyl acetate
CN113717176A (en) Method for preparing remazolam
WO2006132424A1 (en) Process for production of 4(3h)-quinazolinone derivative
WO2022104599A1 (en) N-heterocyclic carbene catalyst and preparation method therefor
WO2010023512A1 (en) Novel vanilloid receptor modulators, process for their preparation and pharmaceutical compositions containing them
US5440036A (en) 1,4-benzoxazine derivatives
KR100950629B1 (en) 8-alkoxy-4-methyl-3,4-dihydro-quinazolin-2-yl amines and their use as 5-ht5a receptor ligands
US7579483B2 (en) Process for preparing 7-(acryloyl)indoles
CN108530368B (en) Method for catalyzing addition reaction of barbituric acid and diene dinitrile by organic base
US10836751B2 (en) Methods for preparing Nintedanib and intermediates thereof
CN101429125B (en) Synthesis of (7-methoxy-3, 4-dihydrogen-1-naphthyl) ethyl acetate
CN109467558B (en) 1-hydropyrrolizine derivative and synthesis method and application thereof
JP2005531545A (en) Method for preparing benazepril hydrochloride
CN111269211B (en) Preparation method of benzothiophene derivative
KR101348440B1 (en) One-pot Synthesis Method of Quinazoline-2,4-dione Derivatives
CN107935909A (en) A kind of Nintedanib(nintedanib)And its synthetic method of intermediate
CN108997250B (en) Method for multi-step synthesis of 2-benzyl-1, 5-dihydrobenzo [ e ] [1,4] oxazepine
CN111233759A (en) Process for preparing apatinib
JP2002173476A (en) 1,4-phenylenediamine derivative and method for producing the same

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20111026

Termination date: 20161109